VALERIE AVALLONE: Open Payments
NPI 1093472458 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 38 payments from 14 companies in 2025. Trend: 2023 $1,005 · 2024 $780 · 2025 $786
Food & beverage: $702Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $204 |
| Madrigal Pharmaceuticals | 7 | $143 |
| ABBVIE INC. | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Lilly USA, LLC | 3 | $54 |
| GENZYME CORPORATION | 2 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| QOL Medical, LLC | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, ENTYVIO, OMVOH, XIFAXAN, RINVOQ, Sucraid.
Industry payments across GA — which companies pay providers there.
